Opinion
Video
Robert Gabbay, MD, PhD, discusses research showing that early intervention with a recent FDA-approved therapy can delay the onset of type 1 diabetes by an average of 2-3 years.
The Impact of COVID-19 on Asthma Diagnosis, Health Care Utilization
Frameworks for Advancing Health Equity: Urban Health Outreach
Exercise, Diet Interventions Boost Fat-Free Mass, Reduce Fatigue in Patients With OC
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
Key Features of Rare Fibrin-Assisted Diffuse Large B-Cell Lymphoma
Aiwu Ruth He, MD, PhD, Discusses 3-Year Survival Data for Durvalumab Plus Chemo in Biliary Tract Cancer, Other Advances